JRF

Debanjan Mukherjee is a pharmaceutical scientist specializing in pharmaceutics, nanoformulation, and analytical method development. He obtained his M.Pharm in Pharmaceutical Quality Assurance from ISF College of Pharmacy, affiliated with I.K. Gujral Punjab Technical University, India. His postgraduate research focused on the development and characterization of targeted nanocarrier systems, particularly pegylated liposomes co-loaded with paclitaxel and berberine for breast cancer therapy. His research interests include nanocarrier-based drug delivery systems, targeted cancer therapy, analytical method development, and the integration of artificial intelligence in drug discovery and biomedical research. He has hands-on experience with advanced analytical and characterization techniques including UV spectroscopy, FTIR, DSC, HPLC, nano spray drying, and lyophilization. Debanjan has authored several peer-reviewed research and review articles in international journals covering topics such as nanomedicine, artificial intelligence in healthcare, drug discovery, and emerging therapeutic strategies. He also holds a published patent related to hyaluronic acid–conjugated pegylated liposomal systems for breast cancer treatment. Currently, he serves as a Lecturer at C.V. Raman Global University, Bhubaneswar, India, where his work focuses on advancing pharmaceutical research and fostering interdisciplinary collaboration in nanomedicine and drug delivery technologies.